<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Programmed <z:hpo ids='HP_0011420'>death</z:hpo>-1 (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>-1), expressed by activated T cells, is a negative regulator of T lymphocytes </plain></SENT>
<SENT sid="1" pm="."><plain>The associations of the immune response-related genes with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> have been demonstrated </plain></SENT>
<SENT sid="2" pm="."><plain>In this study, the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>-1.5 C/T (+7785) polymorphism was investigated in 200 colorectal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients and 200 healthy individuals as controls by nested polymerase chain reaction-restriction fragment length polymorphism method </plain></SENT>
<SENT sid="3" pm="."><plain>The genotype and allele frequencies at <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>-1.5 position were not significantly different between control individuals and the overall <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients </plain></SENT>
<SENT sid="4" pm="."><plain>However, subdivision of the patients by the location (175 <z:hpo ids='HP_0003003'>colon cancer</z:hpo> and 25 rectal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>) revealed a significant difference between <z:hpo ids='HP_0003003'>colon cancer</z:hpo> patients and healthy individuals (p=0.026), and between colon and <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> patients (p=0.017) </plain></SENT>
<SENT sid="5" pm="."><plain>The frequency of the CT genotype was significantly higher in <z:hpo ids='HP_0003003'>colon cancer</z:hpo> patients than in control individuals (58.3% vs. 44.8%, Bonferroni corrected p-value=0.024; OR=1.74; 95% CI=1.15-2.62), and in <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> patients (58.3% vs. 28.0%, Bonferroni corrected p-value=0.012; OR=3.59; 95% CI=1.42-9.04) </plain></SENT>
<SENT sid="6" pm="."><plain>Characteristics of the patients including age, sex, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> grade and stage were not associated with the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>-1.5 polymorphism </plain></SENT>
<SENT sid="7" pm="."><plain>Our results show a significant association between <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>-1.5 polymorphism and <z:hpo ids='HP_0003003'>colon cancer</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>Larger numbers of patients are required to investigate comprehensively the association of <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>-1.5 polymorphism </plain></SENT>
</text></document>